Precision BioSciences Reports Q2 2026 Results

What Happened

• Precision BioSciences, Inc. (DTIL) filed a Current Report on Form 8-K on August 6, 2026 to furnish a press release announcing its financial results and a business update for the quarter ended June 30, 2026. The press release is included as Exhibit 99.1 to the 8-K.

Key Details

• Press release date: August 6, 2026.
• Reporting period: quarter ended June 30, 2026.
• Exhibit(s) included: Exhibit 99.1 (press release) and Exhibit 104 (cover page interactive XBRL).
• 8-K signed by Chief Financial Officer Naresh Tanna on August 6, 2026.

Why It Matters

• This filing provides the company’s latest quarterly results and business update—material information investors use to assess near-term performance (earnings, revenue, cash position, operational progress).
• The 8-K itself furnishes the press release rather than restating figures in the body; investors should read Exhibit 99.1 for the specific financial metrics, any guidance, and operational highlights that could affect the stock.
• For a full picture, compare the press release details with prior reports and watch for follow-up filings or investor calls for clarification.